Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03101475 |
Title | Synergism of Immunomodulation and Tumor Ablation (ILOC) |
Acronym | ILOC |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | European Organisation for Research and Treatment of Cancer - EORTC |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | SWE | NLD | FRA | DEU | CHE | AUT |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Medical University Vienna - General Hospital AKH | Vienna | Austria | Details | |||
Institut Bergonie | Bordeaux | France | Details | |||
Universitaetsklinikum Carl Gustav Carus | Dresden | Germany | Details | |||
Universitaetsklinikum Leipzig-Ambulanzen/Sprechstunden | Leipzig | Germany | Details | |||
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis | Amsterdam | Netherlands | Details | |||
Radboud University Medical Center Nijmegen | Nijmegen | Netherlands | Details | |||
Karolinska University Hospital - Karolinska Institutet - Danderyds Hospital | Stockholm | Sweden | Details | |||
Inselspital | Bern | Switzerland | Details | |||
Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie | Geneva | Switzerland | Details | |||
UniversitaetsSpital Zurich | Zürich | Switzerland | Details |